Balaxi Pharmaceuticals

quarterly
yearly
ParticularsDec '24Mar '25Jun '25Sep '25Dec '25
Revenue77.2374.5868.9657.7772.64
Expenses71.1664.9168.0756.3871.03
EBITDA7.9310.862.372.753.19
EBIT7.4510.401.912.272.63
Profit Before Tax6.079.670.901.381.61
Net Profit5.368.640.290.210.31
Financial Ratios
Operating Profit Margin10.82%14.24%3.35%4.89%4.40%
Net Profit Margin7.31%11.33%0.41%0.37%0.43%
Earning Per Share (Diluted)0.971.560.050.040.06
Dividends Per Share0.000.000.000.000.00